|
2024-06-07 |
2024-06-05 |
S
Sale
|
Kauffman Michael
Non-Executive Director
|
5,900
-50.0%
1.43
USD 8,437
|
5,900
-50.0%
|
1.43
|
USD 8,437
|
|
|
2024-01-26 |
2024-01-25 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
1,041,700
+486.1%
2.40
USD 2,500,080
|
1,041,700
+486.1%
|
2.40
|
USD 2,500,080
|
|
|
2024-01-26 |
2024-01-25 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
242,200
+32.4%
2.40
USD 581,280
|
242,200
+32.4%
|
2.40
|
USD 581,280
|
|
|
2024-01-26 |
2024-01-25 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
1,841,100
+32.4%
2.40
USD 4,418,640
|
1,841,100
+32.4%
|
2.40
|
USD 4,418,640
|
|
|
2024-01-26 |
2024-01-25 |
B
Purchase
|
GORDON CARL L
Non-Executive Director
Large shareholder
|
1,041,700
+486.1%
2.40
USD 2,500,080
|
1,041,700
+486.1%
|
2.40
|
USD 2,500,080
|
|
|
2024-01-26 |
2024-01-25 |
B
Purchase
|
GORDON CARL L
Non-Executive Director
Large shareholder
|
242,200
+32.4%
2.40
USD 581,280
|
242,200
+32.4%
|
2.40
|
USD 581,280
|
|
|
2024-01-26 |
2024-01-25 |
B
Purchase
|
GORDON CARL L
Non-Executive Director
Large shareholder
|
1,841,100
+32.4%
2.40
USD 4,418,640
|
1,841,100
+32.4%
|
2.40
|
USD 4,418,640
|
|
|
2023-10-02 |
2023-10-02 |
B
Purchase
|
Schor Chen
President & CEO
Executive Director
|
5,500
+14.5%
1.33
USD 7,340
|
5,500
+14.5%
|
1.33
|
USD 7,340
|
|
|
2023-10-02 |
2023-09-29 |
S
Sale
|
Schor Chen
President & CEO
Executive Director
|
5,500
-3.0%
1.36
USD 7,481
|
5,500
-3.0%
|
1.36
|
USD 7,481
|
|
|
2023-10-02 |
2023-09-28 |
B
Purchase
|
Schor Chen
President & CEO
Executive Director
|
5,500
+3.1%
1.42
USD 7,810
|
5,500
+3.1%
|
1.42
|
USD 7,810
|
|
|
2023-10-02 |
2023-09-28 |
S
Sale
|
Schor Chen
President & CEO
Executive Director
|
5,500
-12.7%
1.42
USD 7,810
|
5,500
-12.7%
|
1.42
|
USD 7,810
|
|
|
2023-06-29 |
2023-06-27 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
58,000
+8.4%
2.09
USD 121,220
|
58,000
+8.4%
|
2.09
|
USD 121,220
|
|
|
2023-06-29 |
2023-06-27 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
442,000
+8.4%
2.09
USD 923,780
|
442,000
+8.4%
|
2.09
|
USD 923,780
|
|
|
2023-06-29 |
2023-06-27 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
250,000
+63.0%
2.09
USD 522,500
|
250,000
+63.0%
|
2.09
|
USD 522,500
|
|
|
2023-06-29 |
2023-06-27 |
B
Purchase
|
ORBIMED ADVISORS LLC
Non-Executive Director
Large shareholder
|
125,000
+13.8%
2.09
USD 261,250
|
125,000
+13.8%
|
2.09
|
USD 261,250
|
|
|
2023-06-29 |
2023-06-27 |
B
Purchase
|
GORDON CARL L
Non-Executive Director
Large shareholder
|
58,000
+8.4%
2.09
USD 121,220
|
58,000
+8.4%
|
2.09
|
USD 121,220
|
|
|
2023-06-29 |
2023-06-27 |
B
Purchase
|
GORDON CARL L
Non-Executive Director
Large shareholder
|
442,000
+8.4%
2.09
USD 923,780
|
442,000
+8.4%
|
2.09
|
USD 923,780
|
|
|
2023-06-29 |
2023-06-27 |
B
Purchase
|
GORDON CARL L
Non-Executive Director
Large shareholder
|
250,000
+63.0%
2.09
USD 522,500
|
250,000
+63.0%
|
2.09
|
USD 522,500
|
|
|
2023-06-29 |
2023-06-27 |
B
Purchase
|
GORDON CARL L
Non-Executive Director
Large shareholder
|
125,000
+13.8%
2.09
USD 261,250
|
125,000
+13.8%
|
2.09
|
USD 261,250
|
|
|
2023-02-17 |
2023-02-15 |
PS
Planned sale
|
Healey Don
Chief Technology Officer
Officer
|
4,533
-6.4%
7.57
USD 34,327
|
4,533
-6.4%
|
7.57
|
USD 34,327
|
|
|
2023-02-14 |
2023-02-10 |
PS
Planned sale
|
Healey Don
Chief Technology Officer
Officer
|
10,467
-12.8%
7.98
USD 83,476
|
10,467
-12.8%
|
7.98
|
USD 83,476
|
|
|
2022-11-15 |
2022-11-10 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
30,000
-36.0%
20.06
USD 601,920
|
30,000
-36.0%
|
20.06
|
USD 601,920
|
|
|
2022-11-15 |
2022-11-10 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
9,955
-9.8%
21.03
USD 209,322
|
9,955
-9.8%
|
21.03
|
USD 209,322
|
|
|
2022-11-15 |
2022-11-10 |
PS
Planned sale
|
Aftab Blake
Chief Scientific Officer
Officer
|
6,967
-19.8%
21.00
USD 146,307
|
6,967
-19.8%
|
21.00
|
USD 146,307
|
|
|
2022-11-09 |
2022-11-07 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
30,000
-26.4%
19.05
USD 571,488
|
30,000
-26.4%
|
19.05
|
USD 571,488
|
|
|
2022-11-04 |
2022-11-03 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
24,813
-17.9%
18.04
USD 447,718
|
24,813
-17.9%
|
18.04
|
USD 447,718
|
|
|
2022-11-04 |
2022-11-02 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
500
-0.4%
18.00
USD 9,000
|
500
-0.4%
|
18.00
|
USD 9,000
|
|
|
2022-10-21 |
2022-10-19 |
PS
Planned sale
|
Aftab Blake
Chief Scientific Officer
Officer
|
8,067
-18.7%
16.27
USD 131,250
|
8,067
-18.7%
|
16.27
|
USD 131,250
|
|
|
2022-10-14 |
2022-10-12 |
PS
Planned sale
|
Aftab Blake
Chief Scientific Officer
Officer
|
1,646
-3.1%
15.40
USD 25,348
|
1,646
-3.1%
|
15.40
|
USD 25,348
|
|
|
2022-09-16 |
2022-09-14 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
952
-0.7%
18.00
USD 17,136
|
952
-0.7%
|
18.00
|
USD 17,136
|
|
|
2022-09-13 |
2022-09-13 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
3,371
-2.4%
18.01
USD 60,713
|
3,371
-2.4%
|
18.01
|
USD 60,713
|
|
|
2022-09-13 |
2022-09-12 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
200
-0.1%
18.00
USD 3,600
|
200
-0.1%
|
18.00
|
USD 3,600
|
|
|
2022-09-13 |
2022-09-12 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
66,747
-100.0%
16.77
USD 1,119,307
|
66,747
-100.0%
|
16.77
|
USD 1,119,307
|
|
|
2022-09-13 |
2022-09-09 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
8,094
-10.8%
16.51
USD 133,601
|
8,094
-10.8%
|
16.51
|
USD 133,601
|
|
|
2022-08-05 |
2022-08-03 |
PS
Planned sale
|
Aftab Blake
Chief Scientific Officer
Officer
|
6,968
-15.2%
18.00
USD 125,424
|
6,968
-15.2%
|
18.00
|
USD 125,424
|
|
|
2022-08-03 |
2022-08-01 |
PS
Planned sale
|
Aftab Blake
Chief Scientific Officer
Officer
|
6,968
-13.2%
16.64
USD 115,948
|
6,968
-13.2%
|
16.64
|
USD 115,948
|
|
|
2022-07-07 |
2022-07-05 |
PS
Planned sale
|
Aftab Blake
Chief Scientific Officer
Officer
|
1,363
-2.5%
14.50
USD 19,764
|
1,363
-2.5%
|
14.50
|
USD 19,764
|
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
Galimi Francesco
SVP & Chief Medical Officer
Officer
|
1,775
-2.9%
21.00
USD 37,275
|
1,775
-2.9%
|
21.00
|
USD 37,275
|
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
Galimi Francesco
SVP & Chief Medical Officer
Officer
|
168
-0.3%
21.00
USD 3,528
|
168
-0.3%
|
21.00
|
USD 3,528
|
|
|
2022-04-05 |
2022-04-04 |
PS
Planned sale
|
Galimi Francesco
SVP & Chief Medical Officer
Officer
|
6,036
-9.2%
21.00
USD 126,756
|
6,036
-9.2%
|
21.00
|
USD 126,756
|
|
|
2022-04-05 |
2022-04-01 |
PS
Planned sale
|
Galimi Francesco
SVP & Chief Medical Officer
Officer
|
7,621
-11.3%
21.00
USD 160,041
|
7,621
-11.3%
|
21.00
|
USD 160,041
|
|
|
2022-03-11 |
2022-03-09 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
2,000
-0.6%
14.00
USD 28,000
|
2,000
-0.6%
|
14.00
|
USD 28,000
|
|
|
2022-03-11 |
2022-03-09 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
2,000
-0.6%
14.00
USD 28,000
|
2,000
-0.6%
|
14.00
|
USD 28,000
|
|
|
2022-02-17 |
2022-02-16 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
2,000
-0.6%
14.83
USD 29,664
|
2,000
-0.6%
|
14.83
|
USD 29,664
|
|
|
2022-02-17 |
2022-02-16 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
2,000
-0.6%
14.83
USD 29,664
|
2,000
-0.6%
|
14.83
|
USD 29,664
|
|
|
2022-02-14 |
2022-02-09 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
4,000
-1.1%
14.03
USD 56,121
|
4,000
-1.1%
|
14.03
|
USD 56,121
|
|
|
2022-02-14 |
2022-02-09 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
4,000
-1.1%
14.03
USD 56,118
|
4,000
-1.1%
|
14.03
|
USD 56,118
|
|
|
2022-02-14 |
2022-01-05 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
2,000
-0.5%
16.90
USD 33,799
|
2,000
-0.5%
|
16.90
|
USD 33,799
|
|
|
2022-02-14 |
2022-01-05 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
2,000
-0.5%
16.93
USD 33,864
|
2,000
-0.5%
|
16.93
|
USD 33,864
|
|
|
2022-02-14 |
2022-01-03 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
6,000
-1.6%
18.02
USD 108,131
|
6,000
-1.6%
|
18.02
|
USD 108,131
|
|
|
2022-02-14 |
2022-01-03 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
6,000
-1.6%
18.02
USD 108,125
|
6,000
-1.6%
|
18.02
|
USD 108,125
|
|
|
2021-12-10 |
2021-12-08 |
B
Purchase
|
Sinclair Andrew
Non-Executive Director
|
500,000
+30.5%
14.00
USD 7,000,000
|
500,000
+30.5%
|
14.00
|
USD 7,000,000
|
|
|
2021-06-17 |
2021-06-15 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
1,923
-0.9%
11.16
USD 21,454
|
1,923
-0.9%
|
11.16
|
USD 21,454
|
|
|
2021-06-17 |
2021-06-15 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
1,924
-0.9%
11.16
USD 21,465
|
1,924
-0.9%
|
11.16
|
USD 21,465
|
|
|
2021-06-07 |
2021-06-03 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
8,982
-8.3%
12.06
USD 108,279
|
8,982
-8.3%
|
12.06
|
USD 108,279
|
|
|
2021-06-07 |
2021-06-03 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
7,484
-8.3%
12.06
USD 90,220
|
7,484
-8.3%
|
12.06
|
USD 90,220
|
|
|
2021-05-20 |
2021-05-20 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
900
-0.4%
14.23
USD 12,805
|
900
-0.4%
|
14.23
|
USD 12,805
|
|
|
2021-05-20 |
2021-05-20 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
892
-0.4%
14.23
USD 12,692
|
892
-0.4%
|
14.23
|
USD 12,692
|
|
|
2021-05-21 |
2021-05-19 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
733
-0.7%
13.73
USD 10,062
|
733
-0.7%
|
13.73
|
USD 10,062
|
|
|
2021-05-21 |
2021-05-19 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
8,249
-7.1%
13.42
USD 110,728
|
8,249
-7.1%
|
13.42
|
USD 110,728
|
|
|
2021-05-21 |
2021-05-19 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
612
-0.7%
13.73
USD 8,401
|
612
-0.7%
|
13.73
|
USD 8,401
|
|
|
2021-05-21 |
2021-05-19 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
6,872
-7.1%
13.42
USD 92,244
|
6,872
-7.1%
|
13.42
|
USD 92,244
|
|
|
2021-05-20 |
2021-05-18 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
3,100
-1.4%
14.06
USD 43,573
|
3,100
-1.4%
|
14.06
|
USD 43,573
|
|
|
2021-05-20 |
2021-05-18 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
3,108
-1.4%
14.05
USD 43,676
|
3,108
-1.4%
|
14.05
|
USD 43,676
|
|
|
2021-05-14 |
2021-05-12 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
5,000
-2.2%
13.24
USD 66,205
|
5,000
-2.2%
|
13.24
|
USD 66,205
|
|
|
2021-05-14 |
2021-05-12 |
PS
Planned sale
|
Jakobovits Aya
Non-Executive Director
|
5,000
-2.2%
13.23
USD 66,128
|
5,000
-2.2%
|
13.23
|
USD 66,128
|
|
|
2021-05-07 |
2021-05-05 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
3,670
-3.0%
14.70
USD 53,951
|
3,670
-3.0%
|
14.70
|
USD 53,951
|
|
|
2021-05-07 |
2021-05-05 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
5,312
-4.2%
13.90
USD 73,814
|
5,312
-4.2%
|
13.90
|
USD 73,814
|
|
|
2021-05-07 |
2021-05-05 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
3,058
-3.0%
14.70
USD 44,954
|
3,058
-3.0%
|
14.70
|
USD 44,954
|
|
|
2021-05-07 |
2021-05-05 |
PS
Planned sale
|
Schor Chen
President & CEO
Executive Director
|
4,426
-4.2%
13.90
USD 61,502
|
4,426
-4.2%
|
13.90
|
USD 61,502
|
|
|
2021-04-22 |
2021-04-20 |
PS
Planned sale
|
Schor Chen
President and CEO
Executive Director
|
7,484
-6.7%
12.01
USD 89,846
|
7,484
-6.7%
|
12.01
|
USD 89,846
|
|
|
2021-04-22 |
2021-04-20 |
PS
Planned sale
|
Schor Chen
President and CEO
Executive Director
|
8,982
-6.7%
12.01
USD 107,830
|
8,982
-6.7%
|
12.01
|
USD 107,830
|
|
|
2021-04-08 |
2021-04-06 |
PS
Planned sale
|
Schor Chen
President and CEO
Executive Director
|
7,484
-6.2%
13.04
USD 97,584
|
7,484
-6.2%
|
13.04
|
USD 97,584
|
|
|
2021-04-08 |
2021-04-06 |
PS
Planned sale
|
Schor Chen
President and CEO
Executive Director
|
8,982
-6.2%
13.04
USD 117,116
|
8,982
-6.2%
|
13.04
|
USD 117,116
|
|
|
2021-04-01 |
2021-03-30 |
PS
Planned sale
|
Schor Chen
President and CEO
Executive Director
|
4,500
-3.6%
13.22
USD 59,490
|
4,500
-3.6%
|
13.22
|
USD 59,490
|
|
